POLYPHARMACY IN ELDERLY PATIENTS: A REVIEW
Abstract
Patients above 65yrs of age often present with multiple diseases requiring treatment with more number of drugs which is referred to as polypharmacy. Due to age related changes in the pharmacokinetic & pharmacodyamic parameters, elderly patients may present with adverse drug events, drug interactions and hospitalization resulting in increased morbidity. The aim of our study is to assess the various causes and effects of multiple medications and find measures to reduce and manage polypharmacy. Materials for this review were gathered from medline database. The causes for polypharmacy include multiple comorbidities, multiple hospital visits, consuming over the counter medications and herbal products. Risk of falls is found to increase with polypharmacy and treatment with cardiovascular and psychoactive drugs. With increase in the number of drugs the risk of adverse drug reactions and drug interactions is more. Increase in the medical expenditure and non adherence with the drugs has been associated with polypharmacy. Hence there is a need to evaluate polypharmacy by following various criteria or tools and manage treating the elderly in an effective manner
Key words : polypharmacy, multiple medications, elderly adults, geriatricKeywords:
polypharmacy, multiple medications, elderly adults, geriatricDOI
https://doi.org/10.22270/jddt.v5i2.1082References
Arch Intern Med. 2004 Oct 11; 164(18):1957-9. Polypharmacy: a new paradigm for quality drug therapy in the elderly? Gurwitz JH.
Kennerfalk A., Ruigomez A., Wallander M.A., Wilhelmsen L.,Johansson S. Geriatric drug therapy and healthcare utilization in the United kingdom. Ann. Pharmacother. (2002) 36 797–803
Med J Aust. 2012 Jan 16; 196(1):50-3. A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older. Morgan TK1, Williamson M, Pirotta M, Stewart K, Myers SP, Barnes J.
Stewart, R.B. Polypharmacy in the elderly: a fait accompli?. DICP. 1990;24:321–323. PubMed
Clin Geriatr Med. 1992 Feb;8(1):143-58. Overcoming problems with polypharmacy and drug misuse in the elderly. Montamat SC, Cusack B.
Clin Pharmacol Ther. 2009 Jan;85(1):86-8. doi: 10.1038/clpt.2008.224. Epub 2008 Nov The effects of polypharmacy in older adults. Hilmer SN, Gnjidic D.
Polypharmacy and Aging ; Is there cause for Concern? Lisa Pervin, Phd RN CRRN Gerontology Update ARN Network Feb/March 2008
Clin Pharmacol Ther. 2009 Jan;85(1):86-8. doi: 10.1038/clpt.2008.224. Epub 2008 Nov 26.The effects of polypharmacy in older adults. Hilmer SN, Gnjidic D
Lancet. 2007 Jul 14;370(9582):185-91. The challenge of managing drug interactions in elderly people. Mallet L, Spinewine A, Huang A.
The Relationship between Number of Drugs and Potential Drug-Drug Interactions in the Elderly A Study of Over 600 000 Elderly Patients from the Swedish Prescribed Drug Register Kristina Johnell 1,2 and Inga Klarin1,2,3
Lindblad CI, Hanlon JT, Gross CR, et al. Clinically important drug- disease interactions and their prevalence in older adults. Clin Ther. 2006; 28:1133–43. [PubMed: 16982290
Akazawa M, Imai H, Igarashi A, Tsutani K. Potentially inappropriate medication use in elderly Japanese patients. Am J Geriatr Pharmacother. 2010; 8:146–160. [PubMed: 20439064]
Hovstadius B, Petersson G. The impact of increasing polypharmacy on prescribed drug expenditure-a register-based study in Sweden 2005-2009. Health Policy. 2013; 109:166–74. [PubMed: 23195435]
Bourgeois FT, Shannon MW, Valim C, et al. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf. 2010; 19:901–10. [PubMed: 20623513
Marcum ZA, Amuan ME, Hanlon JT, et al. Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans. J Am Geriatric Soc. 2012; 60:34–41
Predicting nursing home admission in the U.S: a meta-analysis Joseph E Gaugler*, Sue Duval, Keith A Anderson and Robert L Kane
Br J Clin Pharmacol. 2006 Feb;61(2):218-23. Polypharmacy and falls in the middle age and elderly population. Ziere G, Dieleman JP, Hofman A, Pols HA, van der Cammen TJ, Stricker BH.
Tromp AM, Plujim SM, Smit JH, et al. Fall-risk screening test: a positive study of predictors for falls in community-dwelling elderly. J Clin Epidemiol. 2001; 54:837–844. [PubMed: 11470394]
J Am Geriatr Soc. 1999 Jan;47(1):30-9. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. Leipzig RM, Cumming RG, Tinetti ME. Ref : J Am Geriatr Soc. 1999 Jan;47(1):40-50.
Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. Leipzig RM, Cumming RG, Tinetti ME.
Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007; 5:345–51. [PubMed: 18179993]
Clinical pharmacology in the geriatric patient Sarah N. Hilmera *, Andrew J. McLachlanb,c , David G. Le Couteurb
ARMOR : A tool evaluate polypharmacy un elderly persons , Raza Haque, MD Annauls of Long term care June 2009.
Published
Abstract Display: 815 
PDF Downloads: 938 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.